![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MAPKAP1 |
Gene summary for MAPKAP1 |
![]() |
Gene information | Species | Human | Gene symbol | MAPKAP1 | Gene ID | 79109 |
Gene name | MAPK associated protein 1 | |
Gene Alias | JC310 | |
Cytomap | 9q33.3 | |
Gene Type | protein-coding | GO ID | GO:0001932 | UniProtAcc | Q9BPZ7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79109 | MAPKAP1 | CCI_2 | Human | Cervix | CC | 2.19e-12 | 1.38e+00 | 0.5249 |
79109 | MAPKAP1 | CCI_3 | Human | Cervix | CC | 4.16e-13 | 1.09e+00 | 0.516 |
79109 | MAPKAP1 | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.39e-05 | -4.58e-01 | 0.0155 |
79109 | MAPKAP1 | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.25e-03 | -2.93e-01 | -0.1808 |
79109 | MAPKAP1 | HTA11_3361_2000001011 | Human | Colorectum | AD | 3.65e-04 | -4.92e-01 | -0.1207 |
79109 | MAPKAP1 | HTA11_696_2000001011 | Human | Colorectum | AD | 4.88e-02 | -2.07e-01 | -0.1464 |
79109 | MAPKAP1 | HTA11_866_2000001011 | Human | Colorectum | AD | 4.05e-02 | -2.20e-01 | -0.1001 |
79109 | MAPKAP1 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.16e-05 | -4.87e-01 | 0.096 |
79109 | MAPKAP1 | HTA11_10711_2000001011 | Human | Colorectum | AD | 1.46e-02 | -4.62e-01 | 0.0338 |
79109 | MAPKAP1 | HTA11_7696_3000711011 | Human | Colorectum | AD | 2.39e-04 | -2.70e-01 | 0.0674 |
79109 | MAPKAP1 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 5.26e-11 | -3.95e-01 | 0.294 |
79109 | MAPKAP1 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 1.35e-15 | -4.69e-01 | 0.3005 |
79109 | MAPKAP1 | A002-C-010 | Human | Colorectum | FAP | 2.07e-04 | -7.31e-02 | 0.242 |
79109 | MAPKAP1 | A001-C-207 | Human | Colorectum | FAP | 2.22e-05 | -4.08e-01 | 0.1278 |
79109 | MAPKAP1 | A015-C-203 | Human | Colorectum | FAP | 3.19e-33 | -5.10e-01 | -0.1294 |
79109 | MAPKAP1 | A015-C-204 | Human | Colorectum | FAP | 2.61e-05 | -3.93e-01 | -0.0228 |
79109 | MAPKAP1 | A014-C-040 | Human | Colorectum | FAP | 1.97e-05 | -6.02e-01 | -0.1184 |
79109 | MAPKAP1 | A002-C-201 | Human | Colorectum | FAP | 8.16e-11 | -3.73e-01 | 0.0324 |
79109 | MAPKAP1 | A002-C-203 | Human | Colorectum | FAP | 8.52e-05 | -1.83e-01 | 0.2786 |
79109 | MAPKAP1 | A001-C-119 | Human | Colorectum | FAP | 6.73e-15 | -7.08e-01 | -0.1557 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:002176217 | Prostate | BPH | substantia nigra development | 23/3107 | 44/18723 | 5.88e-08 | 1.57e-06 | 23 |
GO:003090114 | Prostate | BPH | midbrain development | 36/3107 | 90/18723 | 1.02e-07 | 2.49e-06 | 36 |
GO:004885715 | Prostate | BPH | neural nucleus development | 28/3107 | 64/18723 | 2.93e-07 | 6.23e-06 | 28 |
GO:00510568 | Prostate | BPH | regulation of small GTPase mediated signal transduction | 78/3107 | 302/18723 | 2.69e-05 | 3.16e-04 | 78 |
GO:00465787 | Prostate | BPH | regulation of Ras protein signal transduction | 53/3107 | 189/18723 | 5.08e-05 | 5.24e-04 | 53 |
GO:00181059 | Prostate | BPH | peptidyl-serine phosphorylation | 79/3107 | 315/18723 | 7.09e-05 | 6.96e-04 | 79 |
GO:00182097 | Prostate | BPH | peptidyl-serine modification | 82/3107 | 338/18723 | 1.73e-04 | 1.48e-03 | 82 |
GO:190040716 | Prostate | BPH | regulation of cellular response to oxidative stress | 28/3107 | 89/18723 | 3.90e-04 | 2.85e-03 | 28 |
GO:190288216 | Prostate | BPH | regulation of response to oxidative stress | 30/3107 | 98/18723 | 4.16e-04 | 3.01e-03 | 30 |
GO:000697919 | Prostate | Tumor | response to oxidative stress | 144/3246 | 446/18723 | 5.75e-15 | 8.52e-13 | 144 |
GO:006219719 | Prostate | Tumor | cellular response to chemical stress | 112/3246 | 337/18723 | 7.53e-13 | 7.67e-11 | 112 |
GO:003459919 | Prostate | Tumor | cellular response to oxidative stress | 92/3246 | 288/18723 | 8.68e-10 | 4.22e-08 | 92 |
GO:000726514 | Prostate | Tumor | Ras protein signal transduction | 101/3246 | 337/18723 | 6.29e-09 | 2.44e-07 | 101 |
GO:002176218 | Prostate | Tumor | substantia nigra development | 23/3246 | 44/18723 | 1.35e-07 | 3.45e-06 | 23 |
GO:003090115 | Prostate | Tumor | midbrain development | 36/3246 | 90/18723 | 3.15e-07 | 7.14e-06 | 36 |
GO:004885716 | Prostate | Tumor | neural nucleus development | 28/3246 | 64/18723 | 7.39e-07 | 1.47e-05 | 28 |
GO:005105613 | Prostate | Tumor | regulation of small GTPase mediated signal transduction | 80/3246 | 302/18723 | 3.96e-05 | 4.57e-04 | 80 |
GO:190040717 | Prostate | Tumor | regulation of cellular response to oxidative stress | 30/3246 | 89/18723 | 1.38e-04 | 1.27e-03 | 30 |
GO:004657814 | Prostate | Tumor | regulation of Ras protein signal transduction | 53/3246 | 189/18723 | 1.63e-04 | 1.46e-03 | 53 |
GO:190288217 | Prostate | Tumor | regulation of response to oxidative stress | 31/3246 | 98/18723 | 3.90e-04 | 3.00e-03 | 31 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa04150 | Colorectum | MSS | mTOR signaling pathway | 47/1875 | 156/8465 | 1.19e-02 | 3.99e-02 | 2.44e-02 | 47 |
hsa041501 | Colorectum | MSS | mTOR signaling pathway | 47/1875 | 156/8465 | 1.19e-02 | 3.99e-02 | 2.44e-02 | 47 |
hsa041505 | Esophagus | ESCC | mTOR signaling pathway | 98/4205 | 156/8465 | 5.81e-04 | 1.95e-03 | 9.97e-04 | 98 |
hsa0415013 | Esophagus | ESCC | mTOR signaling pathway | 98/4205 | 156/8465 | 5.81e-04 | 1.95e-03 | 9.97e-04 | 98 |
hsa041502 | Liver | HCC | mTOR signaling pathway | 95/4020 | 156/8465 | 4.70e-04 | 1.99e-03 | 1.11e-03 | 95 |
hsa0415011 | Liver | HCC | mTOR signaling pathway | 95/4020 | 156/8465 | 4.70e-04 | 1.99e-03 | 1.11e-03 | 95 |
hsa041504 | Oral cavity | OSCC | mTOR signaling pathway | 90/3704 | 156/8465 | 2.87e-04 | 9.15e-04 | 4.66e-04 | 90 |
hsa0415012 | Oral cavity | OSCC | mTOR signaling pathway | 90/3704 | 156/8465 | 2.87e-04 | 9.15e-04 | 4.66e-04 | 90 |
hsa0415021 | Oral cavity | EOLP | mTOR signaling pathway | 34/1218 | 156/8465 | 7.59e-03 | 2.17e-02 | 1.28e-02 | 34 |
hsa041503 | Oral cavity | EOLP | mTOR signaling pathway | 34/1218 | 156/8465 | 7.59e-03 | 2.17e-02 | 1.28e-02 | 34 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MAPKAP1 | SNV | Missense_Mutation | c.1079N>G | p.Asp360Gly | p.D360G | Q9BPZ7 | protein_coding | deleterious(0.04) | benign(0.033) | TCGA-AR-A256-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | PD | |
MAPKAP1 | SNV | Missense_Mutation | c.562N>A | p.Asp188Asn | p.D188N | Q9BPZ7 | protein_coding | deleterious(0.01) | possibly_damaging(0.511) | TCGA-D8-A27G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MAPKAP1 | SNV | Missense_Mutation | c.266N>C | p.Arg89Thr | p.R89T | Q9BPZ7 | protein_coding | deleterious(0) | benign(0.428) | TCGA-GM-A2DI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR | |
MAPKAP1 | insertion | Frame_Shift_Ins | novel | c.1503_1504insA | p.Gln502ThrfsTer44 | p.Q502Tfs*44 | Q9BPZ7 | protein_coding | TCGA-BH-A18G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
MAPKAP1 | insertion | In_Frame_Ins | novel | c.650_655dupAAGGAC | p.Gly218_Arg219insGlnGly | p.G218_R219insQG | Q9BPZ7 | protein_coding | TCGA-C8-A26Y-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
MAPKAP1 | SNV | Missense_Mutation | c.1405G>A | p.Glu469Lys | p.E469K | Q9BPZ7 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-C5-A7UH-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
MAPKAP1 | SNV | Missense_Mutation | novel | c.1526N>T | p.Thr509Met | p.T509M | Q9BPZ7 | protein_coding | tolerated(0.06) | probably_damaging(0.998) | TCGA-EA-A410-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
MAPKAP1 | SNV | Missense_Mutation | c.1409N>T | p.Ser470Leu | p.S470L | Q9BPZ7 | protein_coding | deleterious(0.01) | benign(0.269) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
MAPKAP1 | SNV | Missense_Mutation | c.332N>T | p.Arg111Ile | p.R111I | Q9BPZ7 | protein_coding | tolerated(0.18) | probably_damaging(0.94) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
MAPKAP1 | SNV | Missense_Mutation | novel | c.110N>G | p.Asp37Gly | p.D37G | Q9BPZ7 | protein_coding | deleterious(0.02) | probably_damaging(0.955) | TCGA-AA-3947-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
79109 | MAPKAP1 | KINASE | inhibitor | OSI-027 | OSI-027 | |
79109 | MAPKAP1 | KINASE | inhibitor | MLN0128 | SAPANISERTIB | |
79109 | MAPKAP1 | KINASE | inhibitor | AZD8055 | AZD-8055 |
Page: 1 |